Evidence map›Paper›PMID 37891923›Full record

ArticleAntioxidants (Basel, Switzerland)2023

A Comparative Study on UHPLC-HRMS Profiles and Biological Activities of

Gokhan Zengin, Nilofar, Evren Yildiztugay, Abdelhakim Bouyahya, Halit Cavusoglu, Reneta Gevrenova, Dimitrina Zheleva-Dimitrova

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Cyclodextrin-Based Systems ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gokhan ZenginPhysiology and Biochemistry Laboratory, Department of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey.ORCID 0000-0001-6548-7823
NilofarPhysiology and Biochemistry Laboratory, Department of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey.
Evren YildiztugayDepartment of Biotechnology, Science Faculty, Selcuk University, Konya 42130, Turkey.ORCID 0000-0002-4675-2027
Abdelhakim BouyahyaLaboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.ORCID 0000-0001-9317-1631
Halit CavusogluDepartment of Physics, Science Faculty, Selcuk University, Konya 42130, Turkey.
Reneta GevrenovaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-1254-2419
Dimitrina Zheleva-DimitrovaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.ORCID 0000-0002-1952-9903

Funding

European Union's Next Generation EU economic recovery package via the National Recovery and Resilience Plan of the Republic of Bulgaria, project № BG-RRP-2.004-0004-C01. BG-RRP-2.004-0004-C01
6 · The paper itself

Abstract

Within this particular framework, the extracts obtained from

Indexed as

chemical characterizationenzyme inhibitoryInula saranaSEMβ-cyclodextrin

Identifiers

PMID37891923
PMCPMC10604322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.